Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

KaloBios Rises From Bankruptcy Ashes With PRV Still Firmly In Its Sights

Jul 10 2016

• By Alexandra Shimmings

SC1607_PhoenixRising_1200 — • Source: Shutterstock

Related Content

FDA OK's Impavido in leishmaniasis; Knight wins priority voucher

Mar 20 2014

Gilead pays unprecedented $125m for Knight priority voucher

Nov 20 2014

Shkreli's Empire Collapses: KaloBios Seeks Bankruptcy Protection

Dec 31 2015

Related Companies

Vyera Pharmaceuticals, LLC

Travere Therapeutics, Inc.

Bausch Health Companies Inc.

Novartis AG

Knight Therapeutics, Inc.

Gilead Sciences, Inc.

Additional Topics

Companies Business Strategies Infectious Diseases Cancer BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window